Archive of all online issues: July 1994 - August 2017
 |
All content published between 1994 and 1997 is included in the Society for Endocrinology Archive. How to gain access to 1994 - 1997 Archive. |
All content published from March 1998 and more than 12 months old continues to be FREE.
| New Articles: | Recent Issues: | ||
|---|---|---|---|
Issue in progress Vol. 24, Num. 8 |
Vol. 24, Num. 7 |
Vol. 24, Num. 6 |
Vol. 24, Num. 5 |
Full text and abstracts:September 2004 - August 2017
| 2010s | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | - | - |
| 2000s | - | - | - | - | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 |
Full Text (PDF Format Only) and Abstracts:March 1998 - June 2004
| 2000s | 2000 | 2001 | 2002 | 2003 | 2004 | - | - | - | - | - |
| 1990s | - | - | - | - | - | - | - | - | 1998 | 1999 |
Society for Endocrinology Archive
Full text access to this is currently available for purchase (Purchase information)Full text (PDF format only) and abstracts:March 1994 - December 1997
| 1990s | - | - | - | - | 1994 | 1995 | 1996 | 1997 | - | - |
|
How to purchase access to 1994 - 1997 Archive. |
Tweets by @EndoCancer
Most
-
Viewed
- Progesterone metabolites in breast cancer
- Association of Hashimoto's thyroiditis with thyroid cancer
- The emerging roles of DNA methylation in the clinical management of prostate cancer
- Lipomatous tumours in adrenal gland: WHO updates and clinical implications
- Design and validation of specific inhibitors of 17{beta}-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis
-
Cited
- Fibroblast growth factors, their receptors and signaling
- The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification
- BRAF mutation in thyroid cancer
- mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer
- Diabetes and cancer
